F.D.A. Speeds Review of Gene Therapies, Vowing to Target Rogue Clinics

The agency plans to speed approval of treatments to get them to the market faster, signaling the quickened pace of advancements in this field. SHEILA KAPLAN and DENISE GRADY http://ift.tt/2ioV4Vr http://ift.tt/2z8Koor The New York Times Health Stem Cells November 16, 2017 at 12:00AM